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Abstract- Because of an unknown factor, the frequency of complicated pregnancy with placenta previa has 
been raised during past decade. This study was designed to deepen our understanding of risk factors and 
outcomes of placenta previa in our country. This study investigated 694 cases of placenta previa comparing 
with 600 healthy pregnant women with not overlie placenta in two referral and tertiary Obstetrics and 
Gynecological Hospital in Iran on the basis of the clinical and para-clinical analysis, in order to find the 
probable risk factors for occurrence of placenta previa and its effect on maternal and neonatal complications. 
The most important risk factor for the occurrence of placenta previa was advanced maternal age (P<0.001) 
and history of stillbirth (OR=117.2, CI=58.3-236.0). In the other hand, the most substantial outcome of this 
disorder was a reduction of gestational age (P<0.001) and low birth weight neonatally (P<0.001). The 
conservative follow-up should be programmed for women with placenta previa based on the type of risk 
factors which can provide the best possible management to decrease the morbidity and mortality of their 
related complications. 
© 2016 Tehran University of Medical Sciences. All rights reserved.  
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Introduction 
 
Placenta praevia, the growth of placenta in the lower 
uterine segment over or near the internal cervical 
osseous, is an obstetric complication which usually 
occurs in the second trimester (1,2). Although this 
complication is very rare (only <0.5% of all labours), it 
is proved that placenta praevia correlates with morbidity 
and mortality of mother and neonate and needs special 
treatment strategy including restriction of physical 
activity, ability to get immediate medical care, 
contraction controlling, preventing infection and 
hemorrhage as well as timely caesarian section and 
postpartum management (3,4).  
Increasing incidence of placenta praevia during 
recent years posed this question whether this is because 
of improvement of diagnosis or results from other 
modern risk factors (5). Based on newly published 
reports induced labor, artificial abortion, cesarean 
section and high aging pregnancy are associated with 
placenta praevia (6-8). 
This study was conducted to investigate both known 
(e.g. maternal age, the number of gravidity history of 
stillbirth) and modern (e.g. history of placenta previa, 
dilatation and evacuation, caesarean section, abortion) 
risk factors between cases with placenta praevia and 
healthy controls. Moreover maternal and neonatal 
outcomes were evaluated based on the type of risk 
factor.  
 
Materials and Methods 
 
This was a retrospective cohort study of medical 
records of women who had attended the obstetric ward 
at one of two major referral centers for obstetrics and 
gynecology affiliated to Shahid Beheshti and Iran 
Universities of Medical Sciences providing 
comprehensive and multidisciplinary health care 
services for patients. This study was approved by Ethics 
and Research Committee of Shahid Beheshti University 
of Medical Sciences. 
We recruited all patients with the definitive 
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diagnosis of placenta previa (complete or partial 
covering of the internal cervical osseous of uterus by 
placenta tissue confirmed by sonography and during 
caesarian section), those had single fetus, deliver in 
gestational age of 24-41 weeks and attend for treatment 
and follow-up sessions during April 1, 2003 to March 
31, 2010 to conduct a nested case-control observation 
concerning the probable risk factors and outcomes (9).  
Moreover, we excluded the patients having 
incomplete data in their medical files, fetal distress, 
premature rupture of membranous, preeclampsia, and 
another chronic disease from the studied cases list. The 
control group comprised one body mass index (BMI)-
matched healthy pregnant individual for each case from 
same hospital and same year of delivery. Written 
informed consents were obtained from all patients and 
controls. 
A unique questionnaire was filled for each 
participant containing the following items: Age, 
maternal age at delivery, history of substance abuse, 
previous medical history and especial obstetrical history 
(parity, caesarean section, placenta previa, and obstetric 
and postpartum complications). Maternal (time of 
pregnancy termination hysterectomy, blood transfusion 
and duration of hospitalization after delivery) and 
neonatal (fetus presentations, immediate neonatal 
outcomes, APGAR in the 5-minute score, birth weight, 
congenital anomaly and respiratory distress syndrome) 
complications were retrieved from the medical records 
and also assessed in association with risk factors. 
Gestational age was based on the last menstrual period 
(LMP), first-trimester ultrasound or both. Preterm 
delivery was defined as delivery before complete 37 
weeks of gestational age. 
 
Statistical analysis 
Statistical analysis was performed using a 
commercially available software package (SPSS 
Statistics 17.0.0, SPSS, Chicago, Illinois). One-sample 
Kolmogorov-Smirnov test estimated whether data were 
normally distributed. Parametric and nonparametric 
analyses were performed base on the finding of this 
evaluation. A P.value of 0.05 or less was considered 
statistically significant in our study.  
 
Results 
 
During the seven-year study period, 112868 
deliveries occurred in the two hospitals. Placenta previa 
was diagnosed in 771 cases, giving a prevalence of 
placenta previa 0.7% in our survey. Finally, 694 women 
with placenta previa who had inclusion criteria and 
complete medical records were entered into the study as 
well as 600 healthy controls. Although patients and 
controls were matched for BMI, we compared studied 
individuals mean of BMI (24.5±2.8vs. 23.7±1.9; 
P=0.38) which did not show any significant difference. 
Demographic data and risk factors of patients with 
placenta previa were abstracted in (Table 1) in 
comparison with healthy controls. 
 
 
Table 1. Risk factor of placenta previa in 694 pregnant women comparing to 
600 healthy controls 
Risk factors 
Placenta previa 
N=694 
Controls 
N=600 
P.value 
Maternal age; years (mean ± SD) 29.8±6.1 26.3±5.7 <0.001 
Body mass index; kg/cm2 (mean ± SD) 24.5±2.8 23.7±1.9 0.38 
History of multigravidas (%) 134 (19.3) 30 (95) <0.001 
History of still birth (%) 192 (63.9) 9 (89.8) <0.001 
History of dilatation and evacuation (%) 249 (35.8) 61 (10.1) <0.001 
History of placenta previa (%) 13 (1.8) 3 (0.5) 0.041 
History of cesarean section (%) 298 (42.9) 155 (25.8) 0.005 
 
 
Maternal ages were significantly higher in a group of 
placenta previa cases (29.8±6.1 vs. 26.3±5.7; P<0.001). 
(Figure 1) shows the distribution of patients and controls 
in classified age-groups.  
The risk for placenta previa development increased 
with a history of dilatation and evacuation (OR=4.0, 
CI=3.4-7.0), multigravidity (OR=4.5, CI=2.8-7.2), 
history of stillbirth (or=117.2, CI=58.3-236.0), history 
of placenta previa (OR=4.0, CI=1.0-16.3), and history of 
cesarean section (OR=1.5,CI=1.1-2.0). 
Substance abuse was reported only by 4 cases, 
giving a prevalence of 0.4%. The most common 
substance abused was opium (n=2), followed by crack 
(n=1), and methamphetamines (n=1). There was no 
significant difference between substance abusers and 
rest patients in the rate of placenta previa (P=0.17).  
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Expectedly, all evaluated maternal and neonatal 
outcomes of patients with placenta previa were worse 
than normal controls despite congenital anomaly 
(OR=1.09, CI= 0.4-2.9, Table 2). 
To investigate the correlation between the risk 
factors of placenta previa and its secondary 
complication, separate analysis were performed in the 
case group. Maternal age is correlated with 
hospitalization duration after delivery (r=0.63, P=0.02).  
History of stillbirth in placenta previa pregnant 
women is associated with a congenital anomaly 
(P=0.012), and history of previous low-lying placentas 
pregnancy had a greater risk for a decreased APGAR 
score (P=0.043) and respiratory distress syndrome 
(P=0.037). Regarding the history of cesarean section and 
dilatation and evacuation the risk of adverse outcomes 
such as hysterectomy (P=0.0001, P=0.002 respectively) 
and the requirement to blood transfusion (P=0.02 and 
P=0.014 respectively) were increased.  
 
 
 
Figure 1. Age distribution of 694 pregnant women with placenta previa comparing to 600 healthy controls 
 
 
Table 2. Maternal and neonatal outcomes of placenta previa in 694 pregnant women 
comparing to 600 healthy controls 
Parameters 
Placenta previa 
N=694 
Controls 
N=600 
P.value 
Maternal 
Outcomes 
Pregnancy termination; weeks 
(mean ± SD) 
36.1±3.4 38.7±2.6 <0.001 
Hysterectomy after delivery (%) 29 (4.1) 3(0.5) <0.001 
Blood transfusion after delivery 
(%) 
83 (11.9) 21 (3.5) <0.001 
Duration of hospitalization after 
delivery; days (mean ± SD) 
2.2±1.2 1.7±1.4 <0.001 
Neonatal 
Outcomes 
Birth weight; gram (mean ± SD) 2853.3±757.4 3019.2±668.8 0.001 
Congenital anomaly (%) 13 (1.8) 11(1.8) 0.52 
APGAR score at 1 minute <9 (%) 175(25.2) 47(7.8) <0.001 
Non-cephalic presentations (%) 92(13.2) 43 (7.1) 0.002 
Respiratory distress syndrome (%) 215(30.9) 82(13.6) <0.001 
 
 
Discussion 
 
This study investigated the correlation between 
different risk factors and complication of pregnant cases 
with placenta previa for the first time in our center; 
although some of these finding and risk factors have 
been explained more than 20 years ago, the results of 
current study helps to reevaluate data to be applicable to 
today’s conditions. Surprisingly we found the 
association between the proven risk factors for advanced 
maternal age and the secondary outcome of admission 
time after delivery. 
Findings these parameters could help pregnant 
mother with placenta previa through attention to the 
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following strategy in obstetric management which may 
helpful to prevent preterm delivery and neonatal 
morbidity: Conservative management of patient after 
acute bleeding if maternal bleeding is not life 
threatening (10,11), using standardized charts for 
assessment of maternal bleeding it seems helpful to 
determine life-threatening bleeding who needs 
immediate cesarean delivery (12,13), generously using 
tocolysis in pregnancies with placenta previa and 
preterm labor (14,15), and given a course of steroid to 
symptomatic women (16). 
Age of the mothers at the time of pregnancy has been 
reported as the one of the important potential factors 
which impact the placenta previa delivery result 
negatively as well as multiparity, cigarette smoking, 
male sex of the fetus, previous uterine surgical 
procedures, cocaine use during pregnancy, and for 
abnormal placentation in a previous pregnancy 
(17,18,2). Based on the ethnicity of our cases and the 
trend of marriage age in the last decade in our region, 
this factor may be converting to the greatest variable in 
the occurrence of placenta previa in the near future (19). 
However, in recent years several new factors were 
reported as candidate variable in outcomes of placenta 
previa. Type of placentation (complete or incomplete) is 
one of the newly reported factors which may be strongly 
related to a serious complication. However, its impact 
on the outcome of pregnancies has not been elucidated 
completely (20). 
According to the result of the current study we found 
that previous history of cesarean section and dilatation 
and evacuation is associated directly with the 
requirement to hysterectomy and blood transfusion. 
Similar to our findings, Grobman et al., (21) and 
Yaegashi N et al., (22) presented this association, and 
they discussed the preventive management for patients 
with positive history of uterine surgery. It has been 
hypnotized that patients with complete placenta previa 
and previous cesarean deliveries are more susceptible to 
risk of hysterectomy (23). Increased requirement to 
blood transfusion may be associated with severe 
postpartum hemorrhage and the concomitant 
development of placenta accrete (24).   
Although placenta previa correlated with reduction 
of weighing birth of the neonate, we did not record any 
significant increasing in the congenital anomaly of 
babies. Dola et al., reported that infants of pregnant 
cases with complete placenta previa had a lower weight 
at the time of birth and had earlier terminated delivery 
(25). Moreover, it should be noticed that prematurity is a 
consistent complication in studies reporting on all types 
of placenta previa as we seen in our survey. But this 
effect may be due to the age of gestation and premature 
delivery of the cases which was significantly was lower 
than controls. Therefore deciding the strategy for 
postponing the time of delivery especially in incomplete 
type is one the most important of clinical managements 
(1,26). 
The findings of this study suggested that each risk 
factors of placenta previa as a true obstetric emergency 
should be investigated in accordance with secondary 
complications separately. However or results should be 
interpreted with caution because of that some risk factor 
including the habitual history of patients and type of 
placenta previa did not consider in this study. 
Furthermore, our findings need to be confirmed by 
another study in other hospitals and centers in our 
country. 
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